{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:05:57Z","timestamp":1788505557343,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>During lobectomy in patients with lung cancer, the operated lung is often collapsed and hypoperfused. Ischemia\/reperfusion injury may then occur when the lung is re-expanded. We hypothesized that remote ischemic preconditioning (RIPC) would decrease oxidative lung damage and improve gas exchange in the postoperative period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We conducted a single-center, randomized, double-blind trial in patients with nonsmall cell lung cancer undergoing elective lung lobectomy. Fifty-three patients were randomized to receive limb RIPC immediately after anesthesia induction (3 cycles: 5 minutes ischemia\/5 minutes reperfusion induced by an ischemia cuff applied on the thigh) and\/or control therapy without RIPC. Oxidative stress markers were measured in exhaled breath condensate (EBC) and arterial blood immediately after anesthesia induction and before RIPC and surgery (T\n                      <jats:sub>0<\/jats:sub>\n                      , baseline); during operated lung collapse, immediately before resuming two-lung ventilation (TLV) (T\n                      <jats:sub>1<\/jats:sub>\n                      ); immediately after resuming TLV (T\n                      <jats:sub>2<\/jats:sub>\n                      ); and 120 minutes after resuming TLV (T\n                      <jats:sub>3<\/jats:sub>\n                      ). The primary outcome was 8-isoprostane levels in EBC at T\n                      <jats:sub>1<\/jats:sub>\n                      , T\n                      <jats:sub>2<\/jats:sub>\n                      , and T\n                      <jats:sub>3<\/jats:sub>\n                      . Secondary outcomes included the following: NO\n                      <jats:sub>2<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      +NO\n                      <jats:sub>3<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      , H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      levels, and pH in EBC and in blood (8-isoprostane, NO\n                      <jats:sub>2<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      +NO\n                      <jats:sub>3<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) and pulmonary gas exchange variables (PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      , A-aDO\n                      <jats:sub>2<\/jats:sub>\n                      , a\/A ratio, and respiratory index).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Patients subjected to RIPC had lower EBC 8-isoprostane levels when compared with controls at T\n                      <jats:sub>1<\/jats:sub>\n                      , T\n                      <jats:sub>2<\/jats:sub>\n                      , and T\n                      <jats:sub>3<\/jats:sub>\n                      (differences between means and 95% confidence intervals): \u221215.3 (5.8\u201324.8),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .002; \u221220.0 (5.5\u201334.5),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .008; and \u221210.4 (2.5\u201318.3),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .011, respectively. In the RIPC group, EBC NO\n                      <jats:sub>2<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      +NO\n                      <jats:sub>3<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      and H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      levels were also lower than in controls at T\n                      <jats:sub>2<\/jats:sub>\n                      and T\n                      <jats:sub>1<\/jats:sub>\n                      \u2013T\n                      <jats:sub>3<\/jats:sub>\n                      , respectively (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .05). Blood levels of 8-isoprostane and NO\n                      <jats:sub>2<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      +NO\n                      <jats:sub>3<\/jats:sub>\n                      <jats:sup>\u2212<\/jats:sup>\n                      were lower in the RIPC group at T\n                      <jats:sub>2<\/jats:sub>\n                      (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .05). The RIPC group had better PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      compared with controls at 2 hours, 8 hours, and 24 hours after lobectomy in 95% confidence intervals for differences between means: 78 (10\u2013146), 66 (14\u2013118), and 58 (12\u2013104), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      Limb RIPC decreased EBC 8-isoprostane levels and other oxidative lung injury markers during lung lobectomy. RIPC also improved postoperative gas exchange as measured by PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      ratio.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000002065","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T09:25:55Z","timestamp":1494667555000},"page":"499-506","source":"Crossref","is-referenced-by-count":36,"title":["Remote Ischemic Preconditioning Decreases Oxidative Lung Damage After Pulmonary Lobectomy: A Single-Center Randomized, Double-Blind, Controlled Trial"],"prefix":"10.1213","volume":"125","author":[{"given":"Jos\u00e9","family":"Garc\u00eda-de-la-Asunci\u00f3n","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Perez-Griera","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genaro","family":"Galan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Morcillo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wins","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Garc\u00eda-del-Olmo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Guijarro","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Sarri\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mart\u00ed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Soro","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Belda","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Valencia, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.12-2359","article-title":"Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer; 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.","volume":"143","author":"Howington","year":"2013","journal-title":"Chest"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ejcts.2008.06.020","article-title":"The mortality from acute respiratory distress syndrome after pulmonary resection is reducing: a 10-year single institutional experience.","volume":"34","author":"Tang","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1113\/jphysiol.1983.sp014660","article-title":"The relationship between hypoxic pulmonary vasoconstriction and arterial oxygen tension in the intact dog.","volume":"338","author":"Orchand","year":"1983","journal-title":"J Physiol"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/expphysiol.2006.033506","article-title":"Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia.","volume":"91.5","author":"Guzy","year":"2006","journal-title":"Exp Physiol"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/japplphysiol.00480.2006","article-title":"Point: hypoxic pulmonary vasoconstriction is mediated by increased production of reactive oxygen species.","volume":"101","author":"Ward","year":"2006","journal-title":"J Appl Physiol(1985)"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1378\/chest.117.4.999","article-title":"Oxidative stress after lung resection therapy: a pilot study.","volume":"117","author":"Lases","year":"2000","journal-title":"Chest"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejcts.2004.12.023","article-title":"Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation.","volume":"27","author":"Misthos","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejcts.2005.12.027","article-title":"The degree of oxidative stress is associated with major adverse effects after lung resection: a prospective study.","volume":"29","author":"Misthos","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ALN.0000000000000266","article-title":"Limb remote ischemic preconditioning attenuates lung injury after pulmonary resection under propofol-remifentanil anesthesia: a randomized controlled study.","volume":"121","author":"Li","year":"2014","journal-title":"Anesthesiology"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/ejcts\/ezv207","article-title":"Oxidative lung injury correlates with one-lung ventilation time during pulmonary lobectomy: a study of exhaled breath condensate and blood.","volume":"48","author":"Garc\u00eda-de-la-Asunci\u00f3n","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13510002.2015.1101890","article-title":"Glutathione oxidation correlates with one-lung ventilation time and PO2\/FiO2 ratio during pulmonary lobectomy.","volume":"21","author":"Garc\u00eda-de-la-Asunci\u00f3n","year":"2016","journal-title":"Redox Rep"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.athoracsur.2013.02.049","article-title":"Remote ischemic preconditioning for coronary artery bypass graft operations.","volume":"96","author":"Sabbagh","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1074248411409040","article-title":"Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities.","volume":"16","author":"Przyklenk","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R14-20230812","first-page":"42","article-title":"Effect of remote ischemic preconditioning on myocardial and renal injury: meta-analysis of randomized controlled trials.","volume":"24","author":"Alreja","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00395-015-0467-8","article-title":"Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials.","volume":"110","author":"Le Page","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.05.00029705","article-title":"Exhaled breath condensate: methodological recommendations and unresolved questions.","volume":"26","author":"Horv\u00e1th","year":"2005","journal-title":"Eur Respir J"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"L1067","DOI":"10.1152\/ajplung.2001.280.6.L1067","article-title":"Isoprostanes: an overview and putative roles in pulmonary pathophysiology.","volume":"280","author":"Janssen","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nprot.2006.375","article-title":"Quantification of F2-isoprostanes as a biomarker of oxidative stress.","volume":"2","author":"Milne","year":"2007","journal-title":"Nat Protoc"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrd2222","article-title":"Peroxynitrite: biochemistry, pathophysiology and development of therapeutics.","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2006.01.066","article-title":"Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans.","volume":"47","author":"Cheung","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/CIRCULATIONAHA.106.653782","article-title":"Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism.","volume":"116","author":"Loukogeorgakis","year":"2007","journal-title":"Circulation"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"L111","DOI":"10.1152\/ajplung.00006.2004","article-title":"Extracellular superoxide enhances 5-HT-induced murine pulmonary artery vasoconstriction.","volume":"287","author":"Liu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/hh2401.100426","article-title":"Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B\/1D)-receptor antagonist GR127935.","volume":"89","author":"Keegan","year":"2001","journal-title":"Circ Res"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cvr\/cvn114","article-title":"Remote ischaemic preconditioning: underlying mechanisms and clinical application.","volume":"79","author":"Hausenloy","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/ars.2015.6260","article-title":"Nitrite confers preconditioning and cytoprotection after ischemia\/reperfusion injury through the modulation of mitochondrial function","volume":"23","author":"Portella","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.114.303822","article-title":"Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning.","volume":"114","author":"Rassaf","year":"2014","journal-title":"Circ Res"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4330\/wjc.v7.i10.645","article-title":"Concepts of hypoxic NO signaling in remote ischemic preconditioning.","volume":"7","author":"Totzeck","year":"2015","journal-title":"World J Cardiol"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1213\/00000539-199311000-00016","article-title":"Reperfusion injury and exhaled hydrogen peroxide.","volume":"77","author":"Wilson","year":"1993","journal-title":"Anesth Analg"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"e0128455","DOI":"10.1371\/journal.pone.0128455","article-title":"Limb ischemic preconditioning protects endothelium from oxidative stress by enhancing Nrf2 translocation and upregulating expression of antioxidases.","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"R31-20230812","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00395-015-0474-9","article-title":"Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia-induced cell damage.","volume":"110","author":"Weber","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"R32-20230812","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.1317158110","article-title":"Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart.","volume":"110","author":"Caia","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-20230812","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10877-010-9262-0","article-title":"The changes of pulmonary blood flow in non-ventilated lung during one lung ventilation.","volume":"24","author":"Gong","year":"2010","journal-title":"J Clin Monit Comput"},{"key":"R34-20230812","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1213\/ANE.0000000000000808","article-title":"Lung injury after one-lung ventilation: a review of the pathophysiologic mechanisms affecting the ventilated and the collapsed lung.","volume":"121","author":"Lohser","year":"2015","journal-title":"Anesth Analg"},{"key":"R35-20230812","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jtcvs.2007.05.003","article-title":"One-lung ventilation: for how long?","volume":"134","author":"Tekinbas","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R36-20230812","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/bja\/aen021","article-title":"One-lung ventilation induces hyperperfusion and alveolar damage in the ventilated lung: an experimental study.","volume":"100","author":"Kozian","year":"2008","journal-title":"Br J Anaesth"},{"key":"R37-20230812","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/bja\/aeg083","article-title":"Lung injury after thoracotomy.","volume":"91","author":"Baudouin","year":"2003","journal-title":"Br J Anaesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201708000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:23:57Z","timestamp":1786112637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201708000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000002065","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}